Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Wissenschaftliche/r Mitarbeiter/in, Klinik für Neurologie
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Keine vergangenen Veranstaltungen.
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Apheresis therapies in MOGAD : A retrospective study of 117 therapeutic interventions in 571 attacksIn: Journal of Neurology, Neurosurgery and Psychiatry, Jg. 96, 2025, Nr. 7, S. 639 – 646DOI (Open Access)
-
Dyadic Coping of NMOSD and MOGAD patients and their partners : a sociological and psychological examination of strategies (CoMMOnsense-Study)In: BMJ Neurology Open, Jg. 7, 2025, Nr. 2, e001193DOI (Open Access)
-
The global prevalence of headache disorders of public-health importance : A meta-analysis of population-based individual participant data from 41,614 adults from 17 countriesIn: The Journal of Headache and Pain, Jg. 26, 2025, Nr. 1, 204DOI (Open Access)
-
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease : A prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)In: Journal of Neurology, Neurosurgery and Psychiatry, Jg. 96, 2024, Nr. 3, S. 296 – 305DOI (Open Access)
-
Cognitive Impairment, Associated Clinical Factors, and MR Volumetric Measures in Myelin Oligodendrocyte Glycoprotein-IgG-Associated DiseaseIn: Neurology: Neuroimmunology & Neuroinflammation, Jg. 11, 2024, Nr. 6, e200325DOI (Open Access)
-
Eculizumab Use in Neuromyelitis Optica Spectrum DisordersIn: Neurology, Jg. 103, 2024, Nr. 9, e209888DOI (Open Access)
-
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGADIn: Journal of Neurology, Neurosurgery and Psychiatry, Jg. 96, 2024, Nr. 6, S. 582 – 592DOI (Open Access)
-
Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damageIn: Brain: A Journal of Neurology, Jg. 146, 2023, Nr. 5, S. 1932 – 1949DOI (Open Access)
-
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases COPANMO(G)-StudyIn: Neurology: Neuroimmunology & Neuroinflammation, Jg. 10, 2023, Nr. 2, e200082DOI (Open Access)
-
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapiesIn: Multiple Sclerosis Journal, Jg. 29, 2023, Nr. 6, S. 757 – 761DOI, Online Volltext (Open Access)
-
Cerebrospinal fluid findings in COVID-19 : a multicenter study of 150 lumbar punctures in 127 patientsIn: Journal of Neuroinflammation, Jg. 19, 2022, Nr. 1, 19DOI, Online Volltext (Open Access)
-
Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease : CHANCENMO StudyIn: Neurology, Jg. 98, 2022, Nr. 11, S. e1184 – e1196DOI (Open Access)
-
Report of a fulminant anti-pan-neurofascin-associated neuropathy responsive to rituximab and bortezomibIn: Journal of the Peripheral Nervous System, Jg. 26, 2021, Nr. 4, S. 475 – 480DOI (Open Access)
-
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies : Part 2: Results from 108 lumbar punctures in 80 pediatric patientsIn: Journal of Neuroinflammation, Jg. 17, 2020, Nr. 1, 262DOI (Open Access)
-
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disordersIn: Neurology, Jg. 94, 2020, Nr. 4, S. e407 – e418
-
Headache in Caucasian patients with Moyamoya angiopathy - A systematic cohort studyIn: Cephalalgia, Jg. 37, 2017, Nr. 5, S. 496 – 500
-
Trigemino-autonomic headache and Horner syndrome as a first sign of granulomatous hypophysitisIn: Neurology: Neuroimmunology & Neuroinflammation, Jg. 4, 2017, Nr. 3, S. e332DOI (Open Access)
-
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder : a multicenter retrospective studyIn: Journal of Neurology, Jg. 263, 2016, Nr. 3, S. 575 – 582
-
Headache yesterday in Russia: its prevalence and impact, and their application in estimating the national burden attributable to headache disordersIn: The Journal of Headache and Pain, Jg. 16, 2015, S. 7DOI (Open Access)
-
Persistent postural-perceptual dizziness : A matter of higher, central dysfunction?In: PLoS ONE, Jg. 10, 2015, Nr. 11, S. e0142468DOI (Open Access)
-
Diagnosis, prevalence estimation and burden measurement in population surveys of headache : presenting the HARDSHIP questionnaireIn: The Journal of Headache and Pain, Jg. 15, 2014, S. 3DOI (Open Access)
-
Headache-attributed burden and its impact on productivity and quality of life in Russia : Structured healthcare for headache is urgently neededIn: European Journal of Neurology, Jg. 21, 2014, Nr. 5, S. 758 – 765
-
Impact of headache-attributed burden on productivity and quality of life in russia : structured healthcare is urgently neededIn: The Journal of Headache and Pain, Jg. 15, 2014, Nr. Suppl.1, Abstracts from the 4th European Headache and Migraine Trust International Congress: EHMTIC 2014, S. B3DOI (Open Access)
-
The prevalence of primary headache disorders in Russia : a countrywide surveyIn: Cephalalgia, Jg. 32, 2012, Nr. 5, S. 373 – 381
-
The burden of headache in Russia : Validation of the diagnostic questionnaire in a population-based sampleIn: European Journal of Neurology, Jg. 18, 2011, Nr. 3, S. 454 – 459
-
Meningococcal vaccination strategies in patients with NMOSD or myasthenia gravis treated with complement inhibitors : Setting the stage for German consensus recommendationsIn: Multiple Sclerosis Journal. London: Sage, Jg. 30, 2024, Nr. Suppl. 3, S. 1042 – 1043
-
Association of relapse activity with infections and vaccinations in myelin oligodendrocyte glycoprotein antibody-associated diseaseIn: Multiple Sclerosis Journal. London: Sage, Jg. 29, 2023, Nr. Suppl. 3, S. 679 – 680
-
Cognitive impairment in MOGAD is associated with ADEM-like episodes and deep grey matter atrophy (S40.006)
American Academy of Neurology: Annual Meeting; 22.-27.04.2023; Boston, USA,In: Neurology. Minneapolis; Hagerstown, Md.: American Academy of Neurology, Jg. 100, 2023, Nr. 17, Supplement 2, S40.006 -
Real-world data on eculizumab treatment in NMOSD: high efficacy and potential challenges
American Academy of Neurology: Annual Meeting, 22.-27.04.2023, Boston,In: Neurology. Minneapolis; Hagerstown, Md.: American Academy of Neurology, Jg. 100, 2023, Nr. 17, Supplement 2, P13-5.017 -
Countrywide Population-Based Survey in Russia Reveals High Prevalence of Chronic Daily Headache and Its Association with Low Socioeconomic StatusIn: Neurology. Minneapolis; Hagerstown, Md.: American Academy of Neurology, Jg. 76, 2011, Nr. 9 Suppl. 4, S. A180